Crossmark

Characterization of liver, adipose, and fecal microbiome in obese patients with MASLD: links with disease severity and metabolic dysfunction parameters

Crossref DOI link: https://doi.org/10.1186/s40168-024-02004-7

Published Online: 2025-01-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Schwenger, Katherine J. P.

Copeland, Julia K.

Ghorbani, Yasaman

Chen, Lina

Comelli, Elena M.

Guttman, David S.

Fischer, Sandra E.

Jackson, Timothy D.

Okrainec, Allan

Allard, Johane P.
Funding

Funding for this research was provided by:

Canadian Institutes of Health Research (MOP-126139)

American College of Gastroenterology Bridge Award

Canadian Liver Foundation
License Information

Text and Data Mining valid from 2025-01-14

Version of Record valid from 2025-01-14
More Information

Article History

Received: 8 April 2024

Accepted: 10 December 2024

First Online: 14 January 2025

Declarations

:

: All research was approved by the University Health Network Research Ethics Board (UHN; REB#13–6115-A and REB#21–5623) and was conducted in accordance with both the Declarations of Helsinki and Istanbul, and they were also registered with ClinicalTrials.gov (NCT0185646).

: N/A.

: Author AO receives honoraria from Ethicon and Medtronic for speaking and teaching. EC held the Lawson Family Chair in Microbiome Nutrition Research at the University of Toronto. Other authors declare no conflict of interest.

Document is current

Any future updates will be listed below